Similar Articles
891 Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma
892 Latest developments in precancerous lesions of hepatocellular carcinoma
893 Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review
894 Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo
895 Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma
896 New advances in hepatocellular carcinoma
897 Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy
898 Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization
899 Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment
900 Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA